Ashutosh Chilkoti

NON-IMMUNOGENIC, HIGH DENSITY POEGMA CONJUGATES

#2 | 2025-05-29

US20250171503A1

GENETICALLY ENCODED POLYPEPTIDE FOR AFFINITY CAPTURE AND PURIFICATION OF BIOLOGICS

#3 | 2025-02-13

US20250049729A1

POEGMA-BASED LIPID NANOPARTICLES

#4 | 2024-07-11

US20240226307A9

NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES

#5 | 2024-06-06

US20240181013A1

POEGMA COPOLYMER CONJUGATES AND METHODS OF TREATING DISEASES

#6 | 2024-04-25

US20240131171A1

NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES

#7 | 2024-03-14

US20240083952A1

ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-RESPONSIVE BIOPOLYMER NETWORKS

#8 | 2024-01-04

US20240002448A1

Performing operations; transporting

Genetically encoded polypeptide for affinity capture and purification of biologics

#9 | 2023-10-26

US20230338950A1

MICROFLUIDIC ASSAY DEVICE

#10 | 2023-10-05

US20230314434A1

SEMI-QUANTITATIVE LATERAL FLOW DEVICES

#11 | 2023-06-15

US20230183699A1

Amphiphilic polynucleotides

#12 | 2023-04-06

US20230105233A1

COMPLEX STRUCTURES FROM STIMULI-RESPONSIVE PROTEINS

#13 | 2023-03-30

US20230098149A1

METHODS FOR DETECTING NEUTRALIZING ANTIBODIES

#14 | 2023-03-23

US20230093708A1

PROTEIN NANOPARTICLE DESIGN AND APPLICATION

#15 | 2023-03-23

US20230086188A1

PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION

#16 | 2023-01-05

US20230000952A1

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

#17 | 2022-11-08

US16274978

Compositions and methods for the treatment of trail-resistant cancer

#18 | 2022-06-30

US20220205917A1

Devices and methods for imaging microarray chips

#19 | 2022-04-21

US20220120739A1

CHIPS, DETECTORS, AND METHODS OF MAKING AND USING THE SAME

#20 | 2022-03-31

US20220098248A1

Unstructured non-repetitive polypeptides having lcst behavior

#21 | 2022-01-13

US20220008567A1

LIQUIDLY INJECTABLE, SELF-STABILIZING BIOPOLYMERS FOR THE DELIVERY OF RADIONUCLIDE

#22 | 2021-11-04

US20210340186A1

Genetically encoded polypeptide for affinity capture and purification of biologics

#23 | 2021-10-14

US20210316007A1

NANOPARTICULATE DRUG DELIVERY SYSTEMS

#24 | 2021-10-07

US20210309722A1

Dual agonist fusion proteins

#25 | 2021-08-26

US20210261626A1

Genetically encoded polypeptide for affinity capture and purification of biologics

#26 | 2021-05-27

US20210154143A1

Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents

#27 | 2021-05-06

US20210128734A1

Stimuli-responsive PEG-like polymer-based drug delivery platform

#28 | 2021-03-04

US20210060171A1

Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same

#29 | 2021-02-18

US20210047520A1

TUNABLE NONFOULING SURFACE OF OLIGOETHYLENE GLYCOL

#30 | 2021-02-18

US20210046188A1

Surfaces having reduced non-specific binding and antigenicity

#31 | 2021-01-14

US20210009999A1

Amphiphilic polynucleotides

#32 | 2020-12-03

US20200378916A1

Nonfouling biosensors

#33 | 2020-09-10

US20200282022A1

Performing operations; transporting

Therapeutic agents comprising a BMP-9 peptide and eleastin-like peptides

#34 | 2020-09-03

US20200276553A1

Programmable liquid, gel and biohybrid compartments and methods of use

#35 | 2020-05-28

US20200164082A1

Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs

#36 | 2020-05-14

US20200148724A1

Order and disorder as a design principle for stimuli-responsive biopolymer networks

#37 | 2020-01-23

US20200023083A1

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

#38 | 2020-01-16

US20200017557A1

Unstructured non-repetitive polypeptides having LCST behavior

#39 | 2019-12-26

US20190391141A1

Detection devices and related methods of use

#40 | 2019-11-14

US20190345228A1

TARGETED THERAPEUTIC AGENTS COMPRISING MULTIVALENT PROTEIN-BIOPOLYMER FUSIONS

#41 | 2019-10-31

US20190328662A1

Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly

#42 | 2019-09-19

US20190285623A1

DETECTION AND ASSAY DEVICES AND METHODS OF MAKING AND USING THE SAME

#43 | 2019-03-28

US20190091297A1

Methods of increasing nutrient absorption in the intestine using therapeutic agents comprising GLP-2 and elastin-like peptides

#44 | 2019-03-21

US20190083638A1

NICLOSAMIDE-CONJUGATED POLYPEPTIDE NANOPARTICLES

#45 | 2019-01-24

US20190023743A1

METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION

#46 | 2019-01-17

US20190015520A1

POLYMER CONJUGATES HAVING REDUCED ANTIGENICITY AND METHODS OF USING THE SAME

#47 | 2018-12-27

US20180369399A1

POLYMER CONJUGATES HAVING REDUCED ANTIGENICITY AND METHODS OF USING THE SAME

#48 | 2018-09-13

US20180258157A1

Fibronectin type III domain-based fusion proteins

#49 | 2018-08-16

US20180228908A1

Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same

#50 | 2018-08-09

US20180221496A1

ENZYME-CATALYZED SYNTHESIS OF SITE-SPECIFIC AND STOICHIOMETRIC BIOMOLECULE-POLYMER CONJUGATES

#51 | 2018-08-02

US20180217136A1

Chips, detectors, and methods of making and using the same

#52 | 2018-06-07

US20180155763A1

Non-fouling polymeric surface modification and signal amplification method for biomolecular detection

#53 | 2018-02-08

US20180037609A1

PHASE TRANSITION BIOPOLYMERS AND METHODS OF USE

#54 | 2017-12-21

US20170360946A1

ENZYME-CATALYZED SYNTHESIS OF SITE-SPECIFIC AND STOICHIOMETRIC BIOMOLECULE-POLYMER CONJUGATES

#55 | 2017-08-24

US20170239363A1

Polymer conjugates having reduced antigenicity and methods of using the same

#56 | 2017-08-17

US20170233714A1

Performing operations; transporting

Polymer conjugates having reduced antigenicity and methods of using the same

#57 | 2017-08-03

US20170216808A1

PROGRAMMABLE LIQUID, GEL AND BIOHYBRID COMPARTMENTS AND METHODS OF USE

#58 | 2017-04-20

US20170108496A1

Detection devices and related methods of use

#59 | 2017-03-02

US20170058329A1

Direct detection of RNA by surface initiated enzymatic polymerization

#60 | 2016-12-01

US20160348147A1

Systems and devices for protease detection based on engineered polymers and biopolymers and methods of use

#61 | 2016-11-17

US20160333392A1

Non-fouling polymeric surface modification and signal amplification method for biomolecular detection

#62 | 2016-09-22

US20160271262A1

Hydrogels formed from polypeptide micelles and methods of use thereof

#63 | 2016-08-04

US20160222218A1

Tunable Nonfouling Surface Of Oligoethylene Glycol

#64 | 2016-05-05

US20160122451A1

Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates

#65 | 2016-05-05

US20160120952A1

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

#66 | 2016-04-28

US20160114053A1

Methods and compositions for delivering active agents with enhanced pharmacological properties

#67 | 2016-02-04

US20160030521A1

Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides

#68 | 2015-04-23

US20150112022A1

Phase transition biopolymers and methods of use

#69 | 2015-03-19

US20150080306A1

Therapeutic agents comprising fusions of growth hormone and elastic peptides

#70 | 2014-12-11

US20140364371A1

DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS

#71 | 2014-08-14

US20140228249A1

Detection and assay devices and methods of making and using the same

#72 | 2014-07-31

US20140213516A1

Therapeutic agents comprising fusions of insulin and elastic peptides

#73 | 2014-06-26

US20140180220A1

Tunable Nonfouling Surface Of Oligoethylene Glycol

#74 | 2014-01-23

US20140024600A1

METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION

#75 | 2013-11-21

US20130310538A1

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

#76 | 2013-10-24

US20130281624A1

Phase transition biopolymers and methods of use

#77 | 2013-07-11

US20130178416A1

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

#78 | 2013-07-11

US20130178411A1

Therapeutic agents comprising elastic peptides

#79 | 2013-07-04

US20130172274A1

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

#80 | 2013-06-20

US20130157889A1

Detection devices and related methods of use

#81 | 2013-06-06

US20130143802A1

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

#82 | 2013-06-06

US20130143771A1

Non-fouling polymeric surface modification and signal amplification method for biomolecular detection

#83 | 2013-04-04

US20130085104A1

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

#84 | 2013-04-04

US20130085099A1

Therapeutic agents comprising insulin and elastin-like peptides

#85 | 2013-03-28

US20130079277A1

Methods of treating diabetes using therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptides

#86 | 2013-01-03

US20130005664A1

THERAPEUTIC AGENTS COMPRISING ELASTIC PEPTIDES

#87 | 2012-05-17

US20120121709A1

Phase transition biopolymers and methods of use

#88 | 2011-12-01

US20110294189A1

Biomolecule polymer conjugates and methods for making the same

#89 | 2011-11-17

US20110277683A1

Microstamping Activated Polymer Surfaces

#90 | 2011-09-29

US20110236384A1

DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS

#91 | 2011-08-25

US20110207673A1

METHODS AND COMPOSITIONS FOR MODULATING DRUG-POLYMER ARCHITECTURE, PHARMACOKINETICS AND BIODISTRIBUTION

#92 | 2011-05-26

US20110123487A1

Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides

#93 | 2011-05-12

US20110110866A1

Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imaging

#94 | 2011-02-17

US20110039776A1

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

#95 | 2010-07-29

US20100189643A1

DRUG DELIVERY WITH STIMULUS RESPONSIVE BIOPOLYMERS

#96 | 2010-04-22

US20100099579A1

Non-fouling polymeric surface modification and signal amplification method for biomolecular detection

#97 | 2010-01-28

US20100022455A1

Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide

#98 | 2009-10-29

US20090270317A1

Pharmaceutical compositions comprising bioelastomer fusion proteins

#99 | 2009-10-01

US20090247424A1

Detection assay devices and methods of making and using the same

#100 | 2009-09-03

US20090220455A1